Filter
195
Filtered Results: 195
Text search:
Roche
Diagnostics
Featured
Recommendations
20
New Publications
53
Language
Document type
No document type
122
Guidelines
33
Studies & Reports
21
Fact sheets
9
Manuals
5
Resource Platforms
2
Situation Updates
1
Videos
1
Strategic & Response Plan
1
Countries / Regions
Kenya
7
Global
7
Germany
6
Russia
5
Senegal
4
India
4
South Africa
4
Eastern Europe
4
Nigeria
3
Haiti
3
Tanzania
3
Uganda
2
Philippines
2
Mozambique
2
Brazil
2
Ukraine
2
Western and Central Europe
2
Jamaica
2
Burkina Faso
1
USA
1
Ethiopia
1
Ghana
1
Zambia
1
Syria
1
Ireland
1
Malawi
1
Peru
1
North Macedonia
1
Ecuador
1
Madagascar
1
Lesotho
1
Chile
1
Latin America and the Carribbean
1
Africa
1
Vietnam
1
Uruguay
1
Authors & Publishers
Publication Years
Category
Countries
57
Clinical Guidelines
23
Pharmacy & Technologies
9
Public Health
5
Women & Child Health
5
Key Resources
1
Toolboxes
HIV
25
TB
23
Mental Health
21
COVID-19
21
Zika
14
Rapid Response
11
NCDs
6
Ebola
5
NTDs
5
AMR
4
Pharmacy
4
Disability
3
Refugee
3
Global Health Education
3
Caregiver
3
Conflict
1
Planetary Health
1
Health Financing Toolbox
1
The guidelines are to be used to guide the management of adults with lower respiratory tract infection (LRTI). As will be seen in the following text, this diagnosis, and the other clinical syndromes within this grouping, can be difficult to make acc...
Global tuberculosis report 2022
recommended
The WHO Global Tuberculosis Report 2022 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...
Cervical intraepithelial neoplasia (CIN) is a premalignant lesion that may exist at any one of three stages: CIN1, CIN2, or CIN3. If left untreated, CIN2 or CIN3 (collectively referred to as CIN2+) can progress to cervical cancer. Instead of screening and ... by the standard sequence of cytology, colposcopy, biopsy, and histological confirmation of CIN, an alternative method is to use a ‘screen-and-treat’ approach in which the treatment decision is based on a screening test and treatment is provided soon or, ideally, immediately after a positive screening test. This guideline provides recommendations for strategies for a screen-and-treat programme
Intensificar o reforço das abordagens de monitorização do tratamento através dos testes da carga viral, assim como o diagnóstico pediátrico precoce, será fundamental para garantir cuidados e tratamentos de boa qualidade e o êxito dos program...
Instruction for Use
Due to the anticipated significant rise in VL testing occasioned by Ghana’s adaptation of 2016 ART guidelines, it has become necessary to develop this VL scale-up and operational plan to assure complete client access to laboratory monitoring towards the achievement of the third 90 of the HIV care ...
New England Journal of Medicne NJM 2020 382, 22
You can download the video here https://medbox.org/document/how-to-obtain-a-nasopharyngeal-swab-specimen-video#GO
BMC Medicine201614:112 DOI: 10.1186/s12916-016-0660-0
The National Guidelines for HIV-1 Viral Load Laboratory Testing support plans to scale up viral load (VL) testing to reach the 90-90-90 targets in India. This phased scale-up includes the setup of 70 additional VL testing laboratories nationally. These guidelines include laboratory design considerat...
sthma prevalence is increasing worldwide, and surveys indicate that most patients in developed and developing countries, including South Africa, do not receive optimal care and are therefore not well controlled. Standard management guidelines adapted to in-country realities are important to support ...
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- and middle-income countries, since preparing and storing it ...
Developmental disorders
Chapter C.2
2014 Edition
3rd Edition – July 2017
www.msfaccess.org
J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018
Weekly epidemiological update on COVID-19, 28 September 2022
